Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group

被引：0
|
作者：
C. I. Müller
K. Schulmann
A. Reinacher-Schick
N. Andre
D. Arnold
A. Tannapfel
H. Arkenau
S. A. Hahn
S. H.-J. Schmoll
R. Porschen
W. Schmiegel
U. Graeven
机构：
[1] University Hospital Essen,Institute of Physiology
[2] Ruhr-University of Bochum,Medical Department
[3] Martin Luther University,Medical Department IV, University Clinic
[4] Ruhr-University of Bochum,Institute of Pathology, University Clinic Bergmannsheil
[5] Royal Marsden Hospital and Institute of Cancer Research,Drug Development Unit
[6] Ruhr-University of Bochum,Center for Clinical Research (ZKF, Molecular GI
[7] Medical Department Klinikum Bremen-Ost,Oncology (MGO))
[8] Ruhr-University of Bochum,Division of Gastroenterology and Hepatology, University Hospital Bergmannsheil
[9] Kliniken Maria Hilf GmbH Klinik für Hämatologie,undefined
[10] Onkologie,undefined
[11] Gastroenterologie,undefined
来源：
International Journal of Colorectal Disease | 2008年 / 23卷
关键词：
Colorectal cancer; Microsatellite instability; Chemotherapy; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1033 / 1039
页数：6
相关论文
共 50 条
  • [31] Prognostic factors and applicability of Kohne's prognostic groups in stage IV colorectal cancer patients treated with first-line oxaliplatin and/or irinotecan-based chemotherapy
    Diaz, Roberto
    Aparicio, Jorge
    Segura, Angel
    Pellin, Lorena
    Guerrero, Angel
    Palomar, Laura
    Molina, Jorge
    Gimenez, Sandra
    Ponce, Jose
    Montalar, Joaquin
    ANNALS OF ONCOLOGY, 2004, 15 : 87 - 87
  • [32] Predictive role of a pharmacogenetic profiling in patients with advanced colorectal cancer (ACRC) treated with first-line, 5-fluorouracil/irinotecan chemotherapy
    Ruzzo, A. M.
    Catalano, V
    Bisonni, R.
    Loupakis, F.
    Canestrari, E.
    Santini, D.
    Ficarelli, R.
    Mari, D.
    Maltese, P.
    Schiavon, G.
    Pizzagalli, F.
    Masi, G.
    Safina, V
    Giordani, P.
    Lippe, P.
    Alessandroni, P.
    Giustini, L.
    Falcone, A.
    Tonini, G.
    Silva, R. R.
    Mattioli, R.
    Menichetti, E. T.
    Testa, E.
    Lai, V
    Magnani, M.
    Graziano, F.
    ANNALS OF ONCOLOGY, 2006, 17 : XI41 - XI42
  • [33] Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group
    Schmiegel, W.
    Reinacher-Schick, A.
    Arnold, D.
    Kubicka, S.
    Freier, W.
    Dietrich, G.
    Geissler, M.
    Hegewisch-Becker, S.
    Tannapfel, A.
    Pohl, M.
    Hinke, A.
    Schmoll, H. J.
    Graeven, U.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1580 - 1587
  • [34] The Prognostic and Predictive Value of Carbohydrate Antigen 19-9 in Metastatic Colorectal Cancer Patients with First Line Bevacizumab Containing Chemotherapy
    Jiang, Chang
    Liu, Shousheng
    He, Wenzhuo
    Zhang, Bei
    Xia, Liangping
    JOURNAL OF CANCER, 2017, 8 (08): : 1410 - 1416
  • [35] New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy
    Dong-Hoe Koo
    Min-Hee Ryu
    Mi-Yeon Lee
    Mee-Sun Moon
    Yoon-Koo Kang
    World Journal of Gastroenterology, 2021, 27 (48) : 8357 - 8369
  • [36] New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy
    Koo, Dong-Hoe
    Ryu, Min-Hee
    Lee, Mi-Yeon
    Moon, Mee-Sun
    Kang, Yoon-Koo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (48) : 8357 - 8369
  • [37] Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy
    Bazarbashi, Shouki
    Alghabban, Abdulrahman
    Aseafan, Mohamed
    Aljubran, Ali H.
    Alzahrani, Ahmed
    Elhassan, Tusneem A. M.
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (08) : 2429 - 2438
  • [38] Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy
    Shouki Bazarbashi
    Abdulrahman Alghabban
    Mohamed Aseafan
    Ali H Aljubran
    Ahmed Alzahrani
    Tusneem AM Elhassan
    World Journal of Clinical Cases, 2022, (08) : 2429 - 2438
  • [39] Predictive Value of Optimal Morphologic Response to First-Line Chemotherapy Patients with Colorectal Liver Metastases
    Yoshita, Hiroki
    Hosokawa, Ayumu
    Ueda, Akira
    Ando, Takayuki
    Kajiura, Shinya
    Kato, Hiroshi
    Kawabe, Hideto
    Tomizawa, Gakuto
    Horikawa, Naoki
    Yabuhita, Kazuhisa
    Note, Masayuki
    Sugiyama, Toshiro
    DIGESTION, 2014, 89 (01) : 43 - 48
  • [40] Predictive value of optimal morphologic response to first-line chemotherapy in patients with colorectal liver metastases
    Hosokawa, A.
    Ando, T.
    Yoshita, H.
    Horikawa, N.
    Yabushita, K.
    Kawabe, H.
    Tomizawa, G.
    Kato, H.
    Kashii, T.
    Sugiyama, T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S244 - S244
12345